Shenglin Ma

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet · 2019 · 2.1K citations

Platinum–etoposide Versus Platinum–etoposide, Medicine, Pharmacology +6

Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial

Li Zhang, Shenglin Ma, Xiangqun Song et al. · The Lancet Oncology · 2012 · 225 citations

Medicine, Clinical Trials, Maintenance Therapy +9

Finger-inspired rigid-soft hybrid tactile sensor with superior sensitivity at high frequency

Jinhui Zhang, Haimin Yao, Jiaying Mo et al. · Nature Communications · 2022 · 220 citations · Full text

Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib in a Chinese population

Shenglin Ma, Yaping Xu, Qinghua Deng et al. · Lung Cancer · 2008 · 130 citations

Health Sciences, Radiation Therapy, Medicine +9

Genetic polymorphisms and treatment response in advanced non-small cell lung cancer

Dan Su, Shenglin Ma, Peng Liu et al. · Lung Cancer · 2007 · 106 citations

Genetic Polymorphisms, Medicine, Genetics +11